The Portfolio Armor Substack

The Portfolio Armor Substack

Trade Alert: Buying Time For Biotech

A technical screen pass and a catalyst roadmap stretching into spring.

Portfolio Armor's avatar
Portfolio Armor
Nov 11, 2026
∙ Paid

Buying Time For The Next Catalysts

A biotech idea from our Multibaggers list of stock pickers passed our technical screen in our November 10th results. It has clinical and regulatory catalysts over the next few months.

The clinical and regulatory calendar stretches from late 2026 through the first quarter of 2027.

The trade details and exit plan are below.

Today’s First Multibagger’s Trade

Antibody clearance and clinical catalysts

RSI: 56; Chartmill Technical Rating: 9; Setup Rating: 6; Fundamental Rating: 1.

User's avatar

Continue reading this post for free, courtesy of Portfolio Armor.

Or purchase a paid subscription.
© 2026 Portfolio Armor · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for writing, podcasting, and media founders.